On May 11, 2021 Upsher-Smith Laboratories reported that Financial Summary for the Fiscal Year Ended March 31, 2021 (Press release, Upsher-Smith Laboratories, MAY 11, 2021, View Source [SID1234579908])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

1. Financial Highlights for the Fiscal Year Ended March 31, 2021 (April 1, 2020 to March 31, 2021)
(1） Consolidated Operating Results
(2) Consolidated Financial Position
(3) Consolidated Cash Flows

2. Cash Dividends

Consolidated Financial Statements and Selected Notes
(1) Consolidated Statements of Income and Consolidated Statements of Comprehensive Income

(2) Consolidated Statements of Financial Position

(3) Consolidated statements of Changes in Equity

(4) Consolidated Statements of Cash Flows